Used primarily in the pharmaceutical industry as a key intermediate in the synthesis of dolutegravir, an antiretroviral medication. Dolutegravir is a critical component in the treatment of HIV-1 infection, helping to inhibit the integrase enzyme, which is essential for viral replication. The intermediate plays a vital role in ensuring the efficient and scalable production of the active pharmaceutical ingredient (API), contributing to the availability of effective HIV therapies worldwide. Its precise chemical structure and properties are optimized to facilitate high-yield and cost-effective manufacturing processes, supporting global healthcare efforts in combating HIV/AIDS.